Precision medicine in diabetes: A non-invasive prenatal diagnostic test for the determination of fetal glucokinase mutations.
Details
![Ressource 1](https://serval.unil.ch/static/img/forbidden.png)
UNIL restricted access
State: Public
Version: author
License: CC BY-NC 4.0
Serval ID
serval:BIB_96D52F3B48D1
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Precision medicine in diabetes: A non-invasive prenatal diagnostic test for the determination of fetal glucokinase mutations.
Journal
Journal of diabetes investigation
ISSN
2040-1124 (Electronic)
ISSN-L
2040-1116
Publication state
Published
Issued date
02/2022
Peer-reviewed
Oui
Volume
13
Number
2
Pages
256-261
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Publication Status: ppublish
Abstract
Hyperglycemia caused by mutations in the glucokinase gene, GCK, is the most common form of monogenic diabetes. Prenatal diagnosis is important, as it impacts on treatment. This study reports a monogenic non-invasive prenatal diagnostic (NIPD-M) test on cell-free DNA in maternal plasma using the relative haplotype dosage. In three pregnancies of two families with known maternal GCK mutations, the fetal genotype was determined unambiguously already at 12 weeks of gestation. In summary, proof is provided of the feasibility for NIPD-M in GCK diabetes.
Keywords
Diabetes Mellitus, Diabetes Mellitus, Type 2, Diagnostic Tests, Routine, Female, Glucokinase/genetics, Humans, Mutation, Precision Medicine, Pregnancy, Prenatal Diagnosis, Fetal DNA, Monogenic diabetes, Precision medicine
Pubmed
Web of science
Open Access
Yes
Create date
15/09/2021 10:13
Last modification date
12/03/2022 7:29